Term: Therapeutic Interchange Policy
Last Updated: 2005-12-05
Reimbursing consumers at the rate of the lowest price equivalent drug - a policy that promotes consumer's price sensitivity when selecting among both patented and non-patented products. Uses reference based pricing mechanisms, prescribing protocols, and special authority restrictions to regulate the use of higher priced chemically distinct but therapeutically similar products.